TY - JOUR
T1 - Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet)
T2 - a bottom-up and One Health approach
AU - EU-JAMRAI
AU - Mader, Rodolphe
AU - Bourély, Clémence
AU - Amat, Jean-Philippe
AU - Broens, Els M
AU - Busani, Luca
AU - Callens, Bénédicte
AU - Crespo-Robledo, Paloma
AU - Damborg, Peter
AU - Filippitzi, Maria-Eleni
AU - Fitzgerald, William
AU - Grönthal, Thomas
AU - Haenni, Marisa
AU - Heuvelink, Annet
AU - van Hout, Jobke
AU - Kaspar, Heike
AU - Muñoz Madero, Cristina
AU - Norström, Madelaine
AU - Pedersen, Karl
AU - Pokludova, Lucie
AU - Dal Pozzo, Fabiana
AU - Slowey, Rosemarie
AU - Urdahl, Anne Margrete
AU - Vatopoulos, Alkiviadis
AU - Zafeiridis, Christos
AU - Madec, Jean-Yves
N1 - Funding Information:
We are very grateful to all professionals involved in the definition of national veterinary AMR monitoring scopes and consulted experts from the Federation of Veterinarians in Europe, ECDC, EMA, EFSA and EUCAST, as well as to Lucie Collineau (French Agency for Food, Environmental and Occupational Health and Safety) for providing sound feedback on this work. This work was supported by the Health Programme of the EU (2014? 2020) under grant agreement no. 761296.
Publisher Copyright:
© 2022 The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - BACKGROUND: Building the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) was proposed to strengthen the European One Health antimicrobial resistance (AMR) surveillance approach.OBJECTIVES: To define the combinations of animal species/production types/age categories/bacterial species/specimens/antimicrobials to be monitored in EARS-Vet.METHODS: The EARS-Vet scope was defined by consensus between 26 European experts. Decisions were guided by a survey of the combinations that are relevant and feasible to monitor in diseased animals in 13 European countries (bottom-up approach). Experts also considered the One Health approach and the need for EARS-Vet to complement existing European AMR monitoring systems coordinated by the ECDC and the European Food Safety Authority (EFSA).RESULTS: EARS-Vet plans to monitor AMR in six animal species [cattle, swine, chickens (broilers and laying hens), turkeys, cats and dogs], for 11 bacterial species (Escherichia coli, Klebsiella pneumoniae, Mannheimia haemolytica, Pasteurella multocida, Actinobacillus pleuropneumoniae, Staphylococcus aureus, Staphylococcus pseudintermedius, Staphylococcus hyicus, Streptococcus uberis, Streptococcus dysgalactiae and Streptococcus suis). Relevant antimicrobials for their treatment were selected (e.g. tetracyclines) and complemented with antimicrobials of more specific public health interest (e.g. carbapenems). Molecular data detecting the presence of ESBLs, AmpC cephalosporinases and methicillin resistance shall be collected too.CONCLUSIONS: A preliminary EARS-Vet scope was defined, with the potential to fill important AMR monitoring gaps in the animal sector in Europe. It should be reviewed and expanded as the epidemiology of AMR changes, more countries participate and national monitoring capacities improve.
AB - BACKGROUND: Building the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) was proposed to strengthen the European One Health antimicrobial resistance (AMR) surveillance approach.OBJECTIVES: To define the combinations of animal species/production types/age categories/bacterial species/specimens/antimicrobials to be monitored in EARS-Vet.METHODS: The EARS-Vet scope was defined by consensus between 26 European experts. Decisions were guided by a survey of the combinations that are relevant and feasible to monitor in diseased animals in 13 European countries (bottom-up approach). Experts also considered the One Health approach and the need for EARS-Vet to complement existing European AMR monitoring systems coordinated by the ECDC and the European Food Safety Authority (EFSA).RESULTS: EARS-Vet plans to monitor AMR in six animal species [cattle, swine, chickens (broilers and laying hens), turkeys, cats and dogs], for 11 bacterial species (Escherichia coli, Klebsiella pneumoniae, Mannheimia haemolytica, Pasteurella multocida, Actinobacillus pleuropneumoniae, Staphylococcus aureus, Staphylococcus pseudintermedius, Staphylococcus hyicus, Streptococcus uberis, Streptococcus dysgalactiae and Streptococcus suis). Relevant antimicrobials for their treatment were selected (e.g. tetracyclines) and complemented with antimicrobials of more specific public health interest (e.g. carbapenems). Molecular data detecting the presence of ESBLs, AmpC cephalosporinases and methicillin resistance shall be collected too.CONCLUSIONS: A preliminary EARS-Vet scope was defined, with the potential to fill important AMR monitoring gaps in the animal sector in Europe. It should be reviewed and expanded as the epidemiology of AMR changes, more countries participate and national monitoring capacities improve.
UR - http://www.scopus.com/inward/record.url?scp=85125212615&partnerID=8YFLogxK
U2 - 10.1093/jac/dkab462
DO - 10.1093/jac/dkab462
M3 - Article
C2 - 35022739
SN - 0305-7453
VL - 77
SP - 816
EP - 826
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
IS - 3
ER -